Investigational Site Number :4100007

Incheon, Incheon-gwangyeoksi 21565

0 studies enrolling now · 2 studies all time

What they study most

Dermatitis Atopic, Neurodermatitis

Studies at this site

• Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) — Completed
• Observational Evaluation of Atopic Dermatitis in Pediatric Patients — Running, not enrolling